The expanded approval was based on data from the Phase III EoE KIDS trial, where 66% of children who received the higher dose Dupixent at tiered dosing regimens experienced histological disease remission after 16 weeks of treatment, compared to just 3% in the placebo group, per the press release
The first medication in this class, sitagliptin, received FDA approval in 2006 for the treatment of type 2 diabetes
They are prescription treatments that require a medical review
On one hand, we have the most effective and potentially scalable intervention to the most common chronic disease in the world
Tesamorelin Modified GHRH analog designed for enhanced stability. In research, reduces visceral adipose tissue while increasing GH and IGF-1
May help support healthy aging and longevity* GLP-1 at small doses help the body maintain steadier blood sugar and healthier body composition, which are linked to improved lifespan and healthspan